Stay updated on Eplontersen in ATTR CM: Clinical Trial
Sign up to get notified when there's something new on the Eplontersen in ATTR CM: Clinical Trial page.

Latest updates to the Eplontersen in ATTR CM: Clinical Trial page
- Check3 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 error.SummaryDifference0.2%

- Check10 days agoChange DetectedAn NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the ClinicalTrials.gov page, which continues to show a 403 Forbidden error.SummaryDifference1%

- Check17 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2 on the error page.SummaryDifference0.2%

- Check24 days agoChange DetectedThe footer revision marker changes from v3.7.0 to v3.7.1; the study record remains unavailable behind a 403 Forbidden error.SummaryDifference0.2%

- Check45 days agoChange DetectedAn error page (403 Forbidden) is shown in place of the study record, blocking access to the trial details and related content. This indicates a site availability issue rather than a data update.SummaryDifference18%

- Check59 days agoChange DetectedNew study sites were added to the locations list (including Piedmont Heart of Fayetteville and Atlanta, GA 30309) and several sites were removed, resulting in an updated total of 139 locations.SummaryDifference0.4%

Stay in the know with updates to Eplontersen in ATTR CM: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eplontersen in ATTR CM: Clinical Trial page.